Cooley’s 2019 Life Sciences M&A Year in Review
Cooley M&A
JANUARY 22, 2020
A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in the pharmaceutical, medical and biotech industry reaching $234.2 Year of the Life Sciences Mega-Deals. billion acquisition of The Medicines Company.
Let's personalize your content